The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2017
Although the incidence of Hepatitis B has been decreased a lot recently years, there are still quite a few chronic hepatitis B patients in China. The anti-virus drugs of western medicine such as Entecavir and Tenofovir have been proved effective on decreasing the serum hepatitis B virus (HBV) level, on the other hand, Chinese materia medica showed effective on TCM syndromes of chronic hepatitis B (CHB) such as hypochondriac pain, jaundice and abdominal mass. Besides, the hepatic fibrosis could be delayed after the appropriate treatment of TCM. This study is a multicenter, randomized, open label, parallel group clinical trial to evaluate the efficacy of two different traditional Chinese medicine (TCM) herbal treatment on chronic hepatitis B.
Epistemonikos ID: 7fcb4009e764b19a25ac808587b0f42cb32c8ff1
First added on: Nov 24, 2021